Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens

Veterinary Immunology and Immunopathology

Volumn 95, Issue 3-4, 2003, Pages 145-153

  Garcia Camacho, Lucia ^a,d   Schat, Karel A ^b   Brooks Jr , Randolph ^a   Bounous, Denise I ^a,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cell mediated immunity; Cytotoxic lymphocytes; Genetic resistance; Glycoprotein B; Innate immunity; Marek's disease; MHC restricted cytotoxicity; NK cells

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CELL ACTIVITY; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; IMMUNOMODULATION; INFECTION RESISTANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; VIRUS INFECTION;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 0043237970     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00140-5     Document Type: Article

References (35)

1. Baigent S.J., Davison T.F. Development and composition of lymphoid lesions in the spleens of Marek's disease virus-infected chickens: association with virus spread and the pathogenesis of Marek's disease. Avian Pathol. 28:1999;287-300.
2. Bounous D.I., Goodwin M.A., Brooks R.L. Jr., Lamichhane C.M., Campagnoli R.P., Brown J., Snyder D.B. Immunosuppression and intracellular calcium signaling in splenocytes from chicks infected with chicken anemia virus, CL-I isolate. Avian Dis. 39:1995;135-140.
3. Bumstead N. Genomic map of resistance to Marek's disease. Avian Pathol. 27:1998;S78-S81.
4. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.-P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:1996;77-85.
5. Buscaglia C., Calnek B.W., Schat K.A. Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J. Gen. Virol. 69:1988;1067-1077.
6. Calnek B.W. Lymphoma genesis in Marek's disease. Avian Pathol. 27:1998;S54-S64.
7. Calnek, B.W., Witter, R.L., 1997. Marek's disease. In: Calnek, B.W., Barnes, H.J., Beard, C.W., McDougald, L.R., Saif, Y.M. (Eds.), Diseases of Poultry, 10th ed. Iowa State University Press, Ames, IA, pp. 369-413.
8. Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42:1998;124-132.
9. Döhring C., Colonna M. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur. J. Immunol. 26:1996;365-369.
10. Heller E.D., Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol. 16:1987;51-60.
11. Karrë K. Express yourself or die: peptides, MHC molecules, and NK cells. Science. 267:1995;978-979.
12. Kaufman, J., 1996. Structure and function of the major histocompatibility complex of chickens. In: Davison, F., Payne, L.N., Morris, T.R. (Eds.), Poultry Immunology. Carfax Publishing Company, Aberdeen, UK, pp. 27-82.
13. Kaufman J. The simple chicken major histocompatibility complex: life and death in the face of pathogens and vaccines. Phil. Trans. Roy. Soc. London B. 355:2000;1077-1084.
14. Kaufman J., Salomonsen J. The minimal essential MHC revisited: both peptide-binding and cell surface expression level of MHC molecules are polymorphisms selected by pathogens in chickens. Hereditas. 127:1997;67-73.
15. Kaufman J., Venugopal K. The importance of MHC for Rous sarcoma virus and Marek's disease virus - some Payne-full considerations. Avian Pathol. 27:1998;S82-S87.
16. Lessard M., Hutchings D.L., Spencer J.L., Lillehoj H.S., Gavora J.S. Influence of Marek's disease virus strain AC-1 on cellular immunity in birds carrying endogenous viral genes. Avian Dis. 40:1996;645-653.
17. Markowski-Grimsrud C.J., Schat K.A. Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins. Vet. Immunol. Immunopathol. 90:2002;133-144.
18. Moretta L., Ciccone E., Moretta A., Hoglung P., Ohlen C., Karrë K. Allorecognition by NK cells: nonself or no self? Immunol. Today. 13:1992;300-306.
19. Morimura T., Hattori M., Oshashi K., Sugimoto C., Onuma M. Immunomodulation of peripheral T cells in chickens infected with Marek's disease virus: involvement in immunosuppression. J. Gen. Virol. 76:1995;2979-2985.
20. Morimura T., Oshashi K., Sugimoto C., Onuma M. Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J. Vet. Med. Sci. 60:1998;1-8.
21. Omar A.R., Schat K.A. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late and unique MDV proteins. Virology. 222:1996;87-99.
22. Omar A.R., Schat K.A. Characterization of Marek's disease herpesvirus specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology. 90:1997;579-585.
23. Omar A.R., Schat K.A., Lee L.F., Hunt H.D. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 62:1998;73-82.
24. Schat, K.A., 1996. Immunity to Marek's disease, lymphoid leukosis and reticuloendotheliosis. In: Davison, F., Payne, L.N., Morris, T.R. (Eds.), Poultry Immunology. Carfax Publishing Company, Abingdon, UK, pp. 209-233.
25. Schat, K.A., Davies, C., 2000. Resistance to viral diseases. In: Axford, R.F.E., Owen, J.B., Nicholas, F. (Eds.), Breeding for Disease Resistance in Farm Animals, 2nd ed. CAB International, Wallingford, UK, pp. 271-300.
26. Schat K.A., Markowski-Grimsrud C.J. Immune responses to Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:2000;91-120.
27. Schat K.A., Calnek B.W., Fabricant J. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:1982;593-605.
28. Sharma J.M. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Dis. 25:1981;882-893.
29. Sharma J.M., Okazaki W. Natural killer cell activity in chickens: target cell analysis and effect of antithymoryte serum on effector cells. Infect. Immun. 31:1981;1078-1085.
30. Sharma, J.M., Schat, K.A., 1991. Natural immune functions. In: Sharma, J.M. (Ed), Avian Cellular Immunology. CRC Press, Boca Raton, FL, pp. 51-70.
31. Uni Z., Pratt W.D., Miller M.M., O'Connell P.H., Schat K.A. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells. Vet. Immunol. Immunopathol. 44:1994;57-69.
32. Venugopal K., Payne L.N. Molecular pathogenesis of Marek's disease - recent developments. Avian Pathol. 24:1995;597-609.
33. Weinstock, D., Schat, K.A., 1987. Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. In: Weber, W.T., Ewert, D.L. (Eds.), Avian Immunology. Alan R. Liss, NY, pp. 253-263.
34. Witter R.L. The changing landscape of Marek's disease. Avian Pathol. 27:1998;S46-S53.
35. Witter R.L. Control strategies for Marek's disease: a perspective for the future. Poult. Sci. 77:1998;1197-1203.